Combined cataract extraction and intravitreal bevacizumab in eyes with choroidal neovascularization resulting from age-related macular degeneration

Journal of Cataract and Refractive Surgery

Volumn 35, Issue 9, 2009, Pages 1518-1522

  Furino, Claudio ^a   Ferrara, Andrea ^a   Cardascia, Nicola ^a   Besozzi, Gianluca ^a   Alessio, Giovanni ^a   Sborgia, Luigi ^a   Boscia, Francesco ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CATARACT; CATARACT EXTRACTION; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INTRAOCULAR PRESSURE; LENS IMPLANT; MALE; OPTICAL COHERENCE TOMOGRAPHY; PHACOEMULSIFICATION; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY;

AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CATARACT; CHOROIDAL NEOVASCULARIZATION; FEMALE; HUMANS; INJECTIONS; LENS IMPLANTATION, INTRAOCULAR; MACULAR DEGENERATION; MALE; MIDDLE AGED; PHACOEMULSIFICATION; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITREOUS BODY;

EID: 68349133722     PISSN: 08863350     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrs.2009.04.032     Document Type: Article

References (37)

1. Jonas J.B., Kreissig I., Budde W.M., and Degenring R.F. Cataract surgery combined with intravitreal injection of triamcinolone acetonide. Eur J Ophthalmol 15 (2005) 329-335
2. Estafanous M.F.G., Lowder C.Y., Meisler D.M., and Chauhan R. Phacoemulsification cataract extraction and posterior chamber lens implantation in patients with uveitis. Am J Ophthalmol 131 (2001) 620-625
3. The Eye Diseases Prevalence Research Group. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 122 (2004) 564-572
4. Klein R., Klein B.E.K., Knudtson M.D., Wong T.Y., Cotch M.F., Liu K., Burke G., Saad M.F., and Jacobs Jr. D.R. Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosis. Ophthalmology 113 (2006) 373-380
5. Age-Related Eye Disease Study Research Group. Potential pubic health impact of age-related eye disease study results; AREDS report no. 11. Arch Ophthalmol 121 (2003) 1621-1624
6. Age-Related Eye Disease Study Research Group. Risk factors associated with age-related macular degeneration; a case-control study in the Age-Related Eye Disease Study: Age-Related Eye Disease Study Report number 3. Ophthalmology 107 (2000) 2224-2232
7. West S.K., Rosenthal F.S., Bressler N.M., Bressler S.B., Munoz B., Fine S.L., and Taylor H.R. Exposure to sunlight and other risk factors for age-related macular degeneration. Arch Ophthalmol 107 (1989) 875-879
8. Sperduto R.D., Hiller R., and Seigel D. Lens opacities and senile maculopathy. Arch Ophthalmol 99 (1981) 1004-1008
9. Liu I.Y., White L., and LaCroix A.Z. The association of age- related macular degeneration and lens opacities in the aged. Am J Public Health 79 (1989) 765-769. http://www.ajph.org/cgi/reprint/79/6/765 Accessed May 15, 2009
10. Bockelblink A., Roll S., Ruether K., Rasch R., Greiner W., and Willich S.N. Cataract surgery and the development or progression of age-related macular degeneration: a systematic review. Surv Ophthalmol 53 (2008) 359-367
11. Michels S., Rosenfeld P.J., Puliafito C.A., Marcus E.N., and Venkatraman A.S. Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration; twelve-week results of an uncontrolled open-label clinical study. Ophthalmology 112 (2005) 1035-1047
12. Avery R.L., Pieramici D.J., Rabena M.D., Castellarin A.A., Nasir M.A., and Giust M.J. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 113 (2006) 363-372
13. Bashshur Z.F., Bazarbachi A., Schakal A., Haddad Z.A., El Haibi C.P., and Noureddin B.N. Intravitreal bevacizumab for the management of choroidal neovascularization in age-related macular degeneration. Am J Ophthalmol 142 (2006) 1-9
14. Yoganathan P., Deramo V.A., Lai J.C., Tibrewala R.K., and Fastenberg D.M. Visual improvement following intravitreal bevacizumab (Avastin) in exudative age-related macular degeneration. Retina 26 (2006) 994-998
15. Furino C., Boscia F., Recchimurzo N., Besozzi G., Cardascia N., Sborgia L., Niro A., and Sborgia C. Intravitreal bevacizumab for treatment of naïve subfoveal occultchoroidal neovascularization in age-related macular degeneration. Acta Ophthalmol (Oxford) 87 (2009) 404-407
16. The Age-Related Eye Disease Study Research Group. The Age-Related Eye Disease Study (AREDS) system for classifying cataracts from photographs: AREDS report no. 4. Am J Ophthalmol 131 (2001) 167-175
17. Biro Z., Balla Z., and Kovacs B. Change of foveal and perifoveal thickness measured by OCT after phacoemulsification and IOL implantation. Eye 22 (2008) 8-12. http://www.nature.com/eye/journal/v22/n1/pdf/6702460a.pdf Accessed May 15, 2009
18. Grewing R., and Besker H. Retinal thickness immediately after cataract surgery measured by optical coherence tomography. Ophthalmic Surg Laser 31 (2000) 215-217
19. Hogan M.J., Kimura S.J., and Thygeson P. Signs and symptoms of uveitis. I. Anterior uveitis. Am J Ophthalmol 47 5, part 2 (1959) 155-170
20. ®) for neovascular age-related macular degeneration. Ophthalmic Surg Laser Imaging 36 (2005) 331-335
21. Pollack A., Buckelman A., Zalish M., Leiba H., and Oliver H. The course of age-related macular degeneration following bilateral cataract surgery. Ophthalmic Surg Laser 29 (1998) 286-294
22. Pollack A., Marcovich A., Bukelman A., and Oliver M. Age-related macular degeneration after extracapsular cataract extraction with intraocular lens implantation. Ophthalmology 103 (1996) 1546-1554
23. Chine G., Hullo A., Sahel J., Soubrane G., Espinasse-Berrod M.-A., Schutz D., Bourguignon C., Harpey C., Brault Y., Coste M., Moccatti D., and Bourgeois H. Case-control study of the risk factors for age related macular degeneration; for FRANCE-DMLA Study Group. Br J Ophthalmol 82 (1998) 996-1002. Available at: http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1722735&blobty pe=pdf Accessed May 15, 2009
24. Buch H., Vinding T., la Cour M., Jensen G.B., Prause J.U., and Nielsen N.V. Risk factors for age related maculopathy in a 14-year follow-up study; the Copenhagen City Eye Study. Acta Ophthalmol Scand 83 (2005) 409-418. http://www3.interscience.wiley.com/cgi-bin/fulltext/118668642/PDFSTART Accessed May 15, 2009
25. Cugati S., Mitchell P., Rochtchina E., Tan A.G., Smith W., and Wang J.J. Cataract surgery and the 10-year incidence of age-related maculopathy; the Blue Mountains Eye Study. Ophthalmology 113 (2006) 2020-2025
26. Pham T.Q., Cugati S., Rochtchina E., Mitchell P., Maloof A., and Wang J.J. Early age-related maculopathy in eyes after cataract surgery. Eye 21 (2007) 512-517
27. Wang J.J., Klein R., Smith W., Klein B.E.K., Tomany S., and Mitchell P. Cataract surgery and the 5-year incidence of late-stage age-related maculopathy; pooled findings from the Beaver Dam and Blue Mountains Eye Studies. Ophthalmology 110 (2003) 1960-1967
28. Darzins P., Mitchell P., and Heller R.F. Sun exposure and age-related macular degeneration; an Australian case-control study. Ophthalmology 104 (1997) 770-776
29. Armbrecht A.M., Findlay C., Kaushal S., Aspinall P., Hill A.R., and Dhillon B. Is cataract surgery justified in patients with age related macular degeneration? A visual function and quality of life assessment. Br J Ophthalmol 84 (2000) 1343-1348. Available at: http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1723362&blobty pe=pdf Accessed May 15, 2009
30. Armbrecht A.M., Findlay C., Aspinall P.A., Hill A.R., and Dhillon B. Cataract surgery in patients with age-related macular degeneration: one year outcomes. J Cataract Refract Surg 29 (2003) 686-693
31. Kaiserman I., Kaiserman N., Elhayany A., and Vinker S. Cataract surgery is associated with a higher rate of photodynamic therapy for age-related macular degeneration. Ophthalmology 114 (2007) 278-282
32. Sutter F.K.P., Menghini M., Barthelmes D., Fleischhauer J.C., Kurz-Levin M.M., Bosch M.M., and Helbig H. Is pseudophakia a risk factor for neovascular age-related macular degeneration?. Invest Ophthalmol Vis Sci 48 (2007) 1472-1475. http://www.iovs.org/cgi/reprint/48/4/1472 Accessed May 15, 2009
33. Baatz H., Darawsha R., Ackermann H., Scharioth G.B., de Ortueta D., Pavlidis M., and Hattenbach L.O. Phacoemulsification does not induce neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 49 (2008) 1079-1083. http://www.iovs.org/cgi/reprint/49/3/1079 Accessed May 15, 2009
34. Kliffen M., Sharma H.S., Mooy C.M., Kerkvliet S., and de Jong P.T.V.M. Increased expression of angiogenic growth factors in age-related maculopathy. Br J Ophthalmol 81 (1997) 154-162. Available at: http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1722110&blobty pe=pdf Accessed May 15, 2009
35. Ferrara N., Gerber H.-P., and LeCouter J. The biology of VEGF and its receptors. Nat Med 9 (2003) 669-676. http://www.nature.com/nm/journal/v9/n6/pdf/nm0603-669.pdf Accessed May 15, 2009
36. 2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor. Cancer Res 50 (1990) 1774-1778. http://cancerres.aacrjournals.org/cgi/reprint/50/6/1774 Accessed May 15, 2009
37. Miyake K., and Ibaraki N. Prostaglandins and cystoid macular edema. Surv Ophthalmol 47 suppl 1 (2002) S203-S218